Synonym
Sotalol Hydrochloride; Sotalol HCl; Betapace; Betapace AF; Sotacor; Sotalol Monohydrochloride; Darob; Knoll Pharmaceutical Brand of Sotalol;
IUPAC/Chemical Name
N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide;hydrochloride
InChi Key
VIDRYROWYFWGSY-UHFFFAOYSA-N
InChi Code
InChI=1S/C12H20N2O3S.ClH/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17;/h4-7,9,12-15H,8H2,1-3H3;1H
SMILES Code
CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.Cl
Appearance
White to off-white solid powder.
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
308.82
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Marlés-Torres A, López-García R, Bessa-Jambrina S, Galán-Rodríguez C. Ultra- high-speed liquid chromatography combined with mass spectrometry detection analytical methods for the determination of nitrosamine drug substance-related impurities. J Sep Sci. 2023 Jul;46(13):e2300125. doi: 10.1002/jssc.202300125. Epub 2023 May 7. PMID: 37070833.
2: Allen LaPointe NM, Chen A, Hammill B, DeLong E, Kramer JM, Califf RM. Evaluation of the dofetilide risk-management program. Am Heart J. 2003 Nov;146(5):894-901. doi: 10.1016/S0002-8703(03)00409-5. PMID: 14597941.
3: Conjeevaram R, Chaturvedula A, Betageri GV, Sunkara G, Banga AK. Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation. Pharm Res. 2003 Sep;20(9):1496-501. doi: 10.1023/a:1025726715063. PMID: 14567646.
4: Tuovinen L, Peltonen S, Järvinen K. Drug release from starch-acetate films. J Control Release. 2003 Sep 4;91(3):345-54. doi: 10.1016/s0168-3659(03)00259-1. PMID: 12932712.
5: Shi J, Ludden TM, Melikian AP, Gastonguay MR, Hinderling PH. Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia. J Pharmacokinet Pharmacodyn. 2001 Dec;28(6):555-75. doi: 10.1023/a:1014412521191. PMID: 11999292.
6: Saul JP, Schaffer MS, Karpawich PP, Erickson CC, Epstein MR, Melikian AP, Shi J, Karara AH, Cai B, Hinderling PH. Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia. J Clin Pharmacol. 2001 Jan;41(1):35-43. doi: 10.1177/00912700122009818. PMID: 11144992.
7: Tarvainen T, Svarfvar B, Akerman S, Savolainen J, Karhu M, Paronen P, Järvinen K. Drug release from a porous ion-exchange membrane in vitro. Biomaterials. 1999 Nov;20(22):2177-83. doi: 10.1016/s0142-9612(99)00122-2. PMID: 10555086.
8: Rehm KD, Schnelle K, Dyde CJ, Blümner E, Arendts W. Plasmaspiegel und Wirkung von Sotalol-HCl auf EKG-Zeitintervalle nach parenteraler Applikation an gesunde Probanden [Plasma level and action of sotalol-HCL on the ECG interval after parenteral administration in healthy subjects]. Arzneimittelforschung. 1987 Sep;37(9):1058-62. German. PMID: 3435602.
9: Langemeijer JJ, de Wildt DJ, de Groot G, Sangster B. Central origin of respiratory arrest in beta-blocker intoxication in rats. Toxicol Appl Pharmacol. 1987 Jul;89(3):399-407. doi: 10.1016/0041-008x(87)90159-1. PMID: 3603568.
10: Fredericks AB, Benowitz NL, Savanapridi CY. The cardiovascular and autonomic effects of repeated administration of delta-9-tetrahydrocannabinol to rhesus monkeys. J Pharmacol Exp Ther. 1981 Feb;216(2):247-53. PMID: 6257883.
